#

Prof. Matthew Kiernan

Chief Executive Officer and Institute Director, Neuroscience Research Australia Scientia Professor of Neuroscience at the University of New South Wales, Sydney, Australia Senior Staff Specialist in Neurology, South Eastern Sydney Local Health District

Dementia care is facing immense challenges worldwide, with the growing number of diagnoses and lack of effective therapies. In this video, Professor Matthew Kiernan discusses the complexities of dementia research, including recent insights into neurobiological aetiologies, and promising developments for therapeutics. From targeted monoclonal antibody treatments for specific proteins linked to various forms of dementia, to the critical role of lifestyle and preventative care, Professor Kiernan outlines a multifaceted approach to tackling this global issue.

Related content

image Image A multi-arm, multi-stage platform trial illustration
A multi-arm, multi-stage platform trial illustration
29.04.2025 Alzheimer’s Disease
image Image Drug Delivery Systems to the Brain
Drug Delivery Systems to the Brain

Brain drug delivery systems, allied with their characteristics for overcoming the blood-brain barrier (BBB).

29.04.2025 Alzheimer’s Disease
image Image From One-Size-Fits-All to Precision Medicine
From One-Size-Fits-All to Precision Medicine

The use of a single treatment in heterogeneous populations has proved problematic in clinical trials undertaken in patients with neurodegenerative diseases.

29.04.2025 Alzheimer’s Disease